Zanubrutinib (Brukinsa®) Patient Selection and Management in Mantle Cell Lymphoma

In an effort to promote higher quality patient care NCODA constructed the NCODA Positive Quality Intervention to provide healthcare providers with the support and enhanced education to improve the overall management of patients receiving oral oncolytics. The PQI fosters better care for patients through increased speed to therapy, reduced cost and hospitalization, and by improving persistence and adherence within the medically integrated oncology practice. The PQI in Action serves as a follow up to the PQI and incorporates opinions and experiences from a variety of knowledgeable participants, including those from the medically integrated teams at both American Oncology Network, LLC (AON) and Summit Cancer Centers (SCC). Both practices have successfully implemented Medically Integrated Dispensing (MID) as well as the use of positive quality interventions throughout their care teams to improve how they operationalize treatment with zanubrutinib (Brukinsa).